LifeStance Health Group Inc Forecast, price target & analysts
LifeStance Health Group Inc Target price 2024 - Analyst rating & recommendation
LifeStance Health Group Inc Classifications & Recommendation:
LifeStance Health Group Inc Price Target
| Target Price | $8.63 |
| Price | $7.40 |
| Potential |
16.55%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target LifeStance Health Group Inc 2025 .
The average LifeStance Health Group Inc target price is $8.63.
This is
16.55%
register free of charge
$10.00
35.14%
register free of charge
$7.00
5.41%
register free of charge
|
|
| A rating was issued by 5 analysts: 3 Analysts recommend LifeStance Health Group Inc to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the LifeStance Health Group Inc stock has an average upside potential 2025 of
16.55%
register free of charge
|
Sales and Margin forecast 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.06 | 1.24 |
| 22.82% | 17.42% | |
| EBITDA Margin | -10.13% | 8.93% |
| 36.41% | 188.18% | |
| Net Margin | -18.49% | -5.74% |
| 31.93% | 68.95% |
5 Analysts have issued a sales forecast LifeStance Health Group Inc 2024 . The average LifeStance Health Group Inc sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an LifeStance Health Group Inc EBITDA forecast 2024. The average LifeStance Health Group Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 LifeStance Health Group Inc Analysts have issued a net profit forecast 2024. The average LifeStance Health Group Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.51 | -0.19 |
| 16.39% | 62.75% | |
| P/E | negative | |
| EV/Sales | 2.62 |
2 Analysts have issued a LifeStance Health Group Inc forecast for earnings per share. The average LifeStance Health Group Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the LifeStance Health Group Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
LifeStance Health Group Inc...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
